Aldosterone-stimulated SGK1 activity mediates profibrotic signaling in the mesangium

Journal of the American Society of Nephrology

Volumn 19, Issue 2, 2008, Pages 298-309

  Terada, Yoshio ^a   Kuwana, Hitoshi ^a   Kobayashi, Takahiko ^a   Okado, Tomokazu ^a   Suzuki, Noriko ^a   Yoshimoto, Takanobu ^a   Hirata, Yukio ^a   Sasaki, Sei ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CONNECTIVE TISSUE GROWTH FACTOR; CYTOKINE; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MINERALOCORTICOID; PHOSPHOTRANSFERASE; SERUM AND GLUCOCORTICOID REGULATED KINASE 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; GLOMERULOSCLEROSIS; GLOMERULUS; HYPERTENSION; IN VITRO STUDY; KIDNEY FIBROSIS; KIDNEY INJURY; MALE; MESANGIUM; NEPHRITIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SERUM; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

EID: 39049092072     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2007050531     Document Type: Article

References (44)

1. Anderson S, Meyer TW, Rennke HG, Brenner BM: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 76: 612-619, 1985
2. Cattran DC, Greenwood C, Ritchie S: Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin A nephropathy: A comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy. Am J Kidney Dis 23: 247-254, 1994
3. Ishidoya S, Morrissey J, Cracken MC, Reyes A, Klahr S: Angiotensin II receptor antagonist ameliorates renal tubulo-interstitial fibrosis caused by unilateral renal obstruction. Kidney Int 47: 1285-1294, 1995
4. Rosenberg ME, Smith LJ, Correa-Rotter R, Hostetter TH: The paradox of the renin-angiotensin system in chronic renal disease. Kidney Int 45: 403-410, 1994
5. Hollenberg NK: Implications of species difference for clinical investigation: Studies on the renin-angiotensin system. Hypertension 35: 150-154, 2000
6. Brilla CG, Matsubara LS, Weber KT: Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J Mol Cell Cardiol 25: 563-575, 1993
7. Chrysostomou A, Becker G: Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease. N Engl J Med 345: 925-926, 2001
8. Greene EL, Kren S, Hostetter TH: Role of aldosterone in the remnant kidney model. J Clin Invest 98: 1063-1068, 1996
9. Rocha R, Stier CT Jr, Kifor I, Ochoa-Maya MR, Rennke HG, Williams GH, Adler GK: Aldosterone: A mediator of myocardial necrosis and renal arteriopathy. Endocrinology 141: 3891-3898, 2000
10. Terada Y, Kobayashi T, Kuwana H, Tanaka H, Inoshita S, Kuwahara M, Sasaki S: Aldosterone stimulates proliferation of mesangial cells by activating mitogen-activated protein kinase 1/2, Cyclin D1, and Cyclin A. J Am Soc Nephrol 16: 2296-2305, 2005
11. Bhargava A, Fullerton MJ, Myles K, Purdy TM, Funder JW, Pearce D, Cole TJ: The serum- and glucocorticoid-induced kinase is a physiological mediator of aldosterone action. Endocrinology 142: 1587-1594, 2001
12. Lang F, Böhmer C, Palmada M, Seebohm G, Strutz-Seebohm N, Vallon V: (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms. Physiol Rev 86: 1151-1178, 2006
13. Webster MK, Goya L, Ge Y, Maiyar AC, Firestone GL: Characterization of sgk, a novel member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum. Mol Cell Biol 13: 2031-2040, 1993
14. Waldegger S, Barth P, Raber G, Lang F: Cloning and characterization of a putative human serine/threonine protein kinase transcriptionally modified during anisotonic and isotonic alterations of cell volume. Proc Natl Acad Sci U S A 94: 4440-4445, 1997
15. Shigaev A, Asher C, Latter H, Garty H, Reuveny E: Regulation of sgk by aldosterone and its effects on the epithelial Na(+) channel. Am J Physiol 278: F613-F619, 2000
16. Náray-Fejes-Tóth A, Canessa C, Cleaveland ES, Aldrich G, Fejes-Tóth G: Sgk is an aldosterone-induced kinase in the renal collecting duct: Effects on epithelial Na+ channels. J Biol Chem 274: 16973-16978, 1999
17. Hou J, Speirs HJ, Seckl JR, Brown RW: Sgk1 gene expression in kidney and its regulation by aldosterone: Spatio-temporal heterogeneity and quantitative analysis. J Am Soc Nephrol 13: 1190-1198, 2002
18. Lang F, Klingel K, Wagner CA, Stegen C, Wärntges S, Friedrich B, Lanzendörfer M, Melzig J, Moschen I, Steuer S, Waldegger S, Sauter M, Paulmichl M, Gerke V, Risler T, Gamba G, Capasso G, Kandolf R, Hebert SC, Massry SG, Bröer S: Deranged transcriptional regulation of cell-volume-sensitive kinase hSGK in diabetic nephropathy. Proc Natl Acad Sci U S A 97: 8157-8162, 2000
19. Friedrich B, Wärntges S, Klingel K, Sauter M, Kandolf R, Risler T, Müller GA, Witzgall R, Kriz W, Gröne HJ, Lang F: Up-regulation of the human serum and glucocorticoid-dependent kinase 1 in glomerulonephritis. Kidney Blood Press Res 25: 303-307, 2002
20. Wärntges S, Klingel K, Weigert C, Fillon S, Buck M, Schleicher E, Rodemann HP, Knabbe C, Kandolf R, Lang F: Excessive transcription of the human serum and glucocorticoid dependent kinase hSGK1 in lung fibrosis. Cell Physiol Biochem 12: 135-142, 2002
21. Fillon S, Klingel K, Warntges S, Sauter M, Gabrysch S, Pestel S, Tanneur V, Waldegger S, Zipfel A, Viebahn R, Haussinger D, Broer S, Kandolf R, Lang F: Expression of the serine/threonine kinase hSGK1 in chronic viral hepatitis. Cell Physiol Biochem 12: 47-54, 2002
22. Moussad EE, Brigstock DR: Connective tissue growth factor: What's in a name? Mol Genet Metab 71: 276-292, 2000
23. Wang S, Denichilo M, Brubaker C, Hirschberg R: Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy. Kidney Int 60: 96-105, 2001
24. Ito Y, Aten J, Bende RJ, Oemar BS, Rabelink TJ, Weening JJ, Goldschmeding R: Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 53: 853-861, 1998
25. Riser BL, Varani J, Cortes P, Yee J, Dame M, Sharba AK: Cyclic stretching of mesangial cells up-regulates intercellular adhesion molecule-1 and leukocyte adherence: A possible new mechanism for glomerulosclerosis. Am J Pathol 158: 11-17, 2001
26. Denton MD, Marsden PA, Luscinskas FW, Brenner BM, Brady HR: Cytokine-induced phagocyte adhesion to human mesangial cells: Role of CD11/CD18 integrins and ICAM-1. Am J Physiol 261: F1071-F1079, 1991
27. Hill PA, Lan HY, Nikolic-Paterson DJ, Atkins RC: The ICAM-1/LFA-1 interaction in glomerular leukocytic accumulation in anti-GBM glomerulonephritis. Kidney Int 45: 700-708, 1994
28. Itani OA, Liu KZ, Cornish KL, Campbell JR, Thomas CP: Glucocorticoids stimulate human sgk1 gene expression by activation of a GRE in its 5′-flanking region. Am J Physiol 283: E971-E979, 2002
29. Nishiyama A, Yao L, Nagai Y, Miyata K, Yoshizumi M, Kagami S, Kondo S, Kiyomoto H, Shokoji T, Kimura S, Kohno M, Abe Y: Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats. Hypertension 24: 841-848, 2004
30. Rocha R, Chander PN, Khanna K, Zuckerman A, Stier CT Jr: Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats. Hypertension 31: 451-458, 1998
31. + retention in the sgk1-knockout mouse. J Clin Invest 110: 1263-1268, 2002
32. Biondi RM, Kieloch A, Currie RA, Deak M, Alessi DR: The PIF-binding pocket in PDK1 is essential for activation of S6K and SGK, but not PKB. EMBO J 20: 4380-4390, 2001
33. Han KH, Kang YS, Han SY, Jee YH, Lee MH, Han JY, Kim HK, Kim YS, Cha DR: Spironolactone ameliorates renal injury and connective tissue growth factor expression in type II diabetic rats. Kidney Int 70: 111-120, 2006
34. Vallon V, Wyatt AW, Klingel K, Huang DY, Hussain A, Berchtold S, Friedrich B, Grahammer F, BelAiba RS, Görlach A, Wulff P, Daut J, Dalton ND, Ross J Jr, Flögel U, Schrader J, Osswald H, Kandolf R, Kuhl D, Lang F: SGK1-dependent cardiac CTGF formation and fibrosis following DOCA treatment. J Mol Med 84: 396-404, 2006
35. Zhang L, Cui R, Cheng X, Du J: Antiapoptotic effect of serum and glucocorticoid-inducible protein kinase is mediated by novel mechanism activating IkB kinase. Cancer Res 65: 457-464, 2005
36. Artunc F, Amann K, Nasir O, Friedrich B, Sandulache D, Jahovic N, Risler T, Vallon V, Wulff P, Kuhl D, Lang F: Blunted DOCA/high salt induced albuminuria and renal tubulointerstitial damage in gene-targeted mice lacking SGK1. J Mol Med 84: 737-746, 2006
37. Sugimoto H, Shikata K, Hirata K, Akiyama K, Matsuda M, Kushiro M, Shikata Y, Miyatake N, Miyasaka M, Makino H: Increased expression of intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli: Glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation. Diabetes 46: 2075-2083, 1997
38. Kuster GM, Kotlyar E, Rude MK, Siwik DA, Liao R, Colucci WS, Sam F: Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload. Circulation 111: 420-427, 2005
39. Van de Stolpe A, Caldenhoven E, Stade BG, Koenderman L, Raaijmakers JA, Johnson JP, van der Saag PT: 12-O-tetradecanoylphorbol-13-acetate- and tumor necrosis factor alpha-mediated induction of intercellular adhesion molecule-1 is inhibited by dexamethasone: Functional analysis of the human intercellular adhesion molecular-1 promoter. J Biol Chem 269: 6185-6192, 1994
40. Terada Y, Inoshita S, Nakashima O, Yamada T, Tamamori M, Ito H, Sasaki S, Marumo F: Cyclin D1, p16, and retinoblastoma gene regulate mitogenic signaling of endothelin in rat mesangial cells. Kidney Int 53: 76-83, 1998
41. Terada Y, Tomita K, Homma MK, Nonoguchi H, Yang T, Yamada T, Yuasa Y, Krebs EG, Marumo F: Sequential activation of Raf-1 kinase, mitogen-activated protein (MAP) kinase kinase, MAP kinase, and S6 kinase by hyperosmolality in renal cells. J Biol Chem 269: 31296-31301, 1994
42. Terada Y, Tomita K, Nonoguchi H, Yang T, Marumo F: Different localization and regulation of two types of vasopressin receptor messenger RNA in microdissected rat nephron segments using reverse transcription polymerase chain reaction. J Clin Invest 92: 2339-2345, 1993
43. Park J, Leong ML, Buse P, Maiyar AC, Firestone GA, Hemmings BA: Serum and glucocorticoid-inducible kinase (SGK) is a target of the PI3-kinase-stimulated signaling pathway. EMBO J 18: 3024-3033, 1999
44. Terada Y, Inoshita S, Hanada S, Shimamura H, Kuwahara M, Ogawa W, Kasuga M, Sasaki S, Marumo F: Hyperosmolality activates Akt and regulates apoptosis in renal tubular cells. Kidney Int 60: 553-567, 2001